Literature DB >> 34074729

BCRP/ABCG2 Transporter Regulates Accumulation of Cadmium in Kidney Cells: Role of the Q141K Variant in Modulating Nephrotoxicity.

Xia Wen1, Danielle Kozlosky1, Ranran Zhang1, Cathleen Doherty1, Brian Buckley1, Emily Barrett1, Lauren M Aleksunes2.   

Abstract

Exposure to the environmental pollutant cadmium is ubiquitous, as it is present in cigarette smoke and the food supply. Over time, cadmium enters and accumulates in the kidneys, where it causes tubular injury. The breast cancer resistance protein (BCRP, ATP-Binding Cassette G2 ABCG2) is an efflux transporter that mediates the urinary secretion of pharmaceuticals and toxins. The ABCG2 genetic variant Q141K exhibits altered membrane trafficking that results in reduced efflux of BCRP substrates. Here, we sought to 1) evaluate the in vitro and in vivo ability of BCRP to transport cadmium and protect kidney cells from toxicity and 2) determine whether this protection is impaired by the Q141K variant. Cadmium concentrations, cellular stress, and toxicity were quantified in human embryonic kidney 293 cells expressing an empty vector (EV), BCRP wild-type (WT), or variant (Q141K) gene. Treatment with CdCl2 resulted in greater accumulation of cadmium and apoptosis in EV cells relative to WT cells. Exposure to CdCl2 induced expression of stress-related genes and proteins including MT-1A/MT-2A, NAD(P)H quinone dehydrogenase 1, and heme oxygenase-1 to a higher extent in EV cells compared with WT cells. Notably, the Q141K variant protected against CdCl2-induced activation of stress genes and cytotoxicity, but this protection was to a lesser magnitude than observed with WT BCRP. Lastly, concentrations of cadmium in the kidneys of Bcrp knockout mice were 40% higher than in WT mice, confirming that cadmium is an in vivo substrate of BCRP. In conclusion, BCRP prevents the accumulation of cadmium and protects against toxicity, a response that is impaired by the Q141K variant. SIGNIFICANCE STATEMENT: The breast cancer resistance protein transporter lowers cellular accumulation of the toxic heavy metal cadmium. This protective function is partially attenuated by the Q141K genetic variant in the ABCG2 gene.
Copyright © 2021 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34074729      PMCID: PMC8382159          DOI: 10.1124/dmd.121.000446

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.579


  82 in total

1.  C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.

Authors:  Yasuo Imai; Minoru Nakane; Kumie Kage; Satomi Tsukahara; Etsuko Ishikawa; Takashi Tsuruo; Yoshio Miki; Yoshikazu Sugimoto
Journal:  Mol Cancer Ther       Date:  2002-06       Impact factor: 6.261

2.  Cadmium inhibits ABCG2 transporter function in BeWo choriocarcinoma cells and MCF-7 cells overexpressing ABCG2.

Authors:  M Kummu; E Sieppi; K Wallin; A Rautio; K Vähäkangas; P Myllynen
Journal:  Placenta       Date:  2012-08-11       Impact factor: 3.481

3.  The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.

Authors:  Johan W Jonker; Marije Buitelaar; Els Wagenaar; Martin A Van Der Valk; George L Scheffer; Rik J Scheper; Torsten Plosch; Folkert Kuipers; Ronald P J Oude Elferink; Hilde Rosing; Jos H Beijnen; Alfred H Schinkel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

4.  Heme oxygenase-1 is induced in glia throughout brain by subarachnoid hemoglobin.

Authors:  C P Turner; M Bergeron; P Matz; A Zegna; L J Noble; S S Panter; F R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  1998-03       Impact factor: 6.200

5.  Effect of cadmium on antioxidant enzyme activities and lipid peroxidation in the gills of the clam Ruditapes decussatus.

Authors:  Florence Geret; Angela Serafim; Luisa Barreira; Maria João Bebianno
Journal:  Biomarkers       Date:  2002 May-Jun       Impact factor: 2.658

6.  Activation of Nrf2 in defense against cadmium-induced oxidative stress.

Authors:  Xiaoqing He; Michael G Chen; Qiang Ma
Journal:  Chem Res Toxicol       Date:  2008-05-31       Impact factor: 3.739

Review 7.  Metallothionein protection of cadmium toxicity.

Authors:  Curtis D Klaassen; Jie Liu; Bhalchandra A Diwan
Journal:  Toxicol Appl Pharmacol       Date:  2009-04-09       Impact factor: 4.219

8.  The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme.

Authors:  Partha Krishnamurthy; Douglas D Ross; Takeo Nakanishi; Kim Bailey-Dell; Sheng Zhou; Kelly E Mercer; Balazs Sarkadi; Brian P Sorrentino; John D Schuetz
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

9.  Urinary cadmium levels predict lower lung function in current and former smokers: data from the Third National Health and Nutrition Examination Survey.

Authors:  D M Mannino; F Holguin; H M Greves; A Savage-Brown; A L Stock; R L Jones
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

10.  Intestinal absorption of dietary cadmium in women depends on body iron stores and fiber intake.

Authors:  M Berglund; A Akesson; B Nermell; M Vahter
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.